{"id":"NCT00994318","sponsor":"Vifor Pharma","briefTitle":"Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)","officialTitle":"An Open-label, Multicentre, Randomised, 3-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (Ferinject High and Low Dosage Regimens) Versus Oral Iron for the Treatment of Iron Deficiency Anaemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-12","primaryCompletion":"2013-02","completion":"2014-02","firstPosted":"2009-10-14","resultsPosted":"2014-05-07","lastUpdate":"2014-05-20"},"enrollment":626,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Iron Deficiency Anaemia","Chronic Kidney Disease"],"interventions":[{"type":"DRUG","name":"FCM (Ferric carboxymaltose) high ferritin target","otherNames":["Ferinject","Injectafer"]},{"type":"DRUG","name":"FCM (Ferric carboxymaltose) low ferritin target","otherNames":["Ferinject","Injectafer"]},{"type":"DRUG","name":"Oral Iron (Ferrous sulphate)","otherNames":["Ferrous sulphate"]}],"arms":[{"label":"FCM (high ferritin target)","type":"EXPERIMENTAL"},{"label":"FCM (low ferritin target)","type":"EXPERIMENTAL"},{"label":"Oral Iron","type":"ACTIVE_COMPARATOR"}],"summary":"Phase IIIb study to evaluate the long-term efficacy of ferric carboxymaltose (FCM) (using targeted ferritin levels to determine dosing) or oral iron in non-dialysis-dependent chronic kidney disease (NDD-CKD) subjects with iron deficiency anaemia (IDA).","primaryOutcome":{"measure":"Kaplan-Meier Survival Analysis for Time to Other Anemia Therapy or Hb Trigger","timeFrame":"Up to 1 year after baseline","effectByArm":[{"arm":"FCM (High Ferritin Target)","deltaMin":36,"sd":7.65},{"arm":"FCM (Low Ferritin Level)","deltaMin":49,"sd":9.47},{"arm":"Oral Iron","deltaMin":98,"sd":7.71}],"pValues":[{"comp":"OG000 vs OG002","p":"0.026"},{"comp":"OG000 vs OG001","p":"0.082"},{"comp":"OG000 vs OG002","p":"0.020"},{"comp":"OG000 vs OG001","p":"0.008"},{"comp":"OG000 vs OG002","p":"0.12"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":19,"countries":["United States","Australia","Austria","Belgium","Czechia","Denmark","France","Germany","Greece","Italy","Netherlands","Norway","Poland","Portugal","Romania","Spain","Sweden","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["28339831","28095881","24891437"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":39,"n":154},"commonTop":["Diarrhoea","Oedema Peripheral","Hypertension","Urinary Tract Infection","Constipation"]}}